NCT04005222View on ClinicalTrials.gov

Effects of Selenium and Melatonin on Ocular Ischemic Syndrome

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

November 30, 2016

Conditions
Anterior Segment Ischemia (Diagnosis)
Interventions
DRUG

SELENIUM

Increased lipid peroxidation associated with ischemia of the anterior segment has been prevented by selenium supplementation.

DRUG

MELATONIN

Increased lipid peroxidation associated with ischemia of the anterior segment has been prevented by melatonin supplementation.

All Listed Sponsors
lead

Beytepe Murat Erdi Eker State Hospital

OTHER

NCT04005222 - Effects of Selenium and Melatonin on Ocular Ischemic Syndrome | Biotech Hunter | Biotech Hunter